Pharmaceutical Revenues In China Rising Faster Than Projected
This article was originally published in PharmAsia News
HONG KONG - A recent report by Chinese firm Wicon International suggests revenues from pharmaceutical products in China this year could grow by $12 billion to $82 billion. Total sales in 2008 amounted to about $70 billion
You may also be interested in...
IMS' global pharma forecast points to slow 4 percent to 6 percent growth in 2010, although the outlook is brighter than previously anticipated.
SHANGHAI - China's National Development and Reform Commission issued Oct. 2 a guideline price for its Essential Drug List, which stipulates price ceilings for 296 drugs on the first part of the list
Players That Evolve In Tandem With China's Health System Reforms Will Survive and Prosper, Says Pfizer Executive
BEIJING - With China's entire healthcare environment set to undergo rapid-fire change, propelled by system-wide reforms slated to be progressively implemented over the next decade, players that are the nimblest at adapting to or even promoting the transformation will emerge as the strongest winners